Literature DB >> 11307368

Definition of sepsis.

I Matot1, C L Sprung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11307368     DOI： 10.1007/pl00003795

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  30 in total

1.  Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgery.

Authors:  Nestor González-Roldán; Eduardo Ferat-Osorio; Rosalía Aduna-Vicente; Isabel Wong-Baeza; Noemí Esquivel-Callejas; Horacio Astudillo-de la Vega; Patricio Sánchez-Fernández; Lourdes Arriaga-Pizano; Miguel Angel Villasís-Keever; Constantino López-Macías; Armando Isibasi
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

2.  Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study.

Authors:  E Cadirci; Z Halici; F Odabasoglu; A Albayrak; E Karakus; D Unal; F Atalay; I Ferah; B Unal
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

3.  Effects of ketamine on proinflammatory cytokines and nuclear factor kappaB in polymicrobial sepsis rats.

Authors:  Xue-Min Song; Jian-Guo Li; Yan-Lin Wang; Qing Zhou; Zhao-Hui Du; Bao-Hui Jia; Jian-Juan Ke
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

4.  Crisis management during anaesthesia: sepsis.

Authors:  J A Myburgh; M J Chapman; S M Szekely; G A Osborne
Journal:  Qual Saf Health Care       Date:  2005-06

5.  Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection?

Authors:  Roberto Romero; Nicholas Kadar; Edi Vaisbuch; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-03-15       Impact factor: 3.886

6.  Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.

Authors:  O Senard; M Lafaurie; P Lesprit; Y Nguyen; X Lescure; A Therby; V Fihman; N Oubaya; R Lepeule
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-11       Impact factor: 3.267

7.  Effect of N-acetylcysteine and fructose-1,6-bisphosphate in the treatment of experimental sepsis.

Authors:  Ricardo Obalski de Mello; Adroaldo Lunardelli; Eduardo Caberlon; Cristina Machado Bragança de Moraes; Roberto Christ Vianna Santos; Vinicius Lorini da Costa; Gabriela Viegas da Silva; Patrícia da Silva Scherer; Luiz Eduardo Coimbra Buaes; Denizar Alberto da Silva Melo; Márcio Vinícius Fagundes Donadio; Fernanda Bordignon Nunes; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

Review 8.  Targeting HMGB1 in inflammation.

Authors:  Huan Yang; Kevin J Tracey
Journal:  Biochim Biophys Acta       Date:  2009-12-03

9.  Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients.

Authors:  Farjana B Rowther; Camilla S Rodrigues; Minal S Deshmukh; Farhad N Kapadia; Ashit Hegde; Ajita P Mehta; Vinay R Joshi
Journal:  J Clin Microbiol       Date:  2009-07-29       Impact factor: 5.948

10.  Secular trends in severe renal failure associated with the use of new antimicrobial agents in critically ill surgical patients.

Authors:  M E Eichhorn; H Wolf; H Küchenhoff; M Joka; K-W Jauch; W H Hartl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.